Medifast Inc. (MED)
Medifast Statistics
Share Statistics
Medifast has 10.94M shares outstanding. The number of shares has increased by 0.01% in one year.
| Shares Outstanding | 10.94M |
| Shares Change (YoY) | 0.01% |
| Shares Change (QoQ) | 0% |
| Owned by Institutions (%) | 81.59% |
| Shares Floating | 10.48M |
| Failed to Deliver (FTD) Shares | 251 |
| FTD / Avg. Volume | 0.11% |
Short Selling Information
The latest short interest is 1.38M, so 12.64% of the outstanding shares have been sold short.
| Short Interest | 1.38M |
| Short % of Shares Out | 12.64% |
| Short % of Float | 19.2% |
| Short Ratio (days to cover) | 6.9 |
Valuation Ratios
The PE ratio is 92.1 and the forward PE ratio is -24.33. Medifast's PEG ratio is -0.94.
| PE Ratio | 92.1 |
| Forward PE | -24.33 |
| PS Ratio | 0.32 |
| Forward PS | 0.3 |
| PB Ratio | 0.92 |
| P/FCF Ratio | 11.31 |
| PEG Ratio | -0.94 |
Enterprise Valuation
Medifast has an Enterprise Value (EV) of 117.78M.
| EV / Sales | 0.2 |
| EV / EBITDA | 40.93 |
| EV / EBIT | 4.81 |
| EV / FCF | 6.92 |
Financial Position
The company has a current ratio of 3.34, with a Debt / Equity ratio of 0.08.
| Current Ratio | 3.34 |
| Quick Ratio | 2.68 |
| Debt / Equity | 0.08 |
| Debt / EBITDA | 5.6 |
| Debt / FCF | 0.95 |
| Interest Coverage | 0 |
Financial Efficiency
Return on Equity is 1% and Return on Invested Capital is 0.7%.
| Return on Equity | 1% |
| Return on Assets | 0.74% |
| Return on Invested Capital | 0.7% |
| Revenue Per Employee | $1.2M |
| Profits Per Employee | $4.15K |
| Employee Count | 504 |
| Asset Turnover | 2.12 |
| Inventory Turnover | 3.72 |
Taxes
| Income Tax | 1.7M |
| Effective Tax Rate | 44.78% |
Stock Price Statistics
The stock price has increased by -63.13% in the last 52 weeks. The beta is 1.08, so Medifast's price volatility has been higher than the market average.
| Beta | 1.08 |
| 52-Week Price Change | -63.13% |
| 50-Day Moving Average | 13.99 |
| 200-Day Moving Average | 17.3 |
| Relative Strength Index (RSI) | 33.95 |
| Average Volume (20 Days) | 230K |
Income Statement
In the last 12 months, Medifast had revenue of 602.46M and earned 2.09M in profits. Earnings per share was 0.19.
| Revenue | 602.46M |
| Gross Profit | 444.62M |
| Operating Income | 2.88M |
| Net Income | 2.09M |
| EBITDA | 2.88M |
| EBIT | 2.88M |
| Earnings Per Share (EPS) | 0.19 |
Balance Sheet
The company has 90.93M in cash and 16.13M in debt, giving a net cash position of 74.8M.
| Cash & Cash Equivalents | 90.93M |
| Total Debt | 16.13M |
| Net Cash | 74.8M |
| Retained Earnings | 176.78M |
| Total Assets | 284.21M |
| Working Capital | 150.24M |
Cash Flow
In the last 12 months, operating cash flow was 24.48M and capital expenditures -7.45M, giving a free cash flow of 17.02M.
| Operating Cash Flow | 24.48M |
| Capital Expenditures | -7.45M |
| Free Cash Flow | 17.02M |
| FCF Per Share | 1.56 |
Margins
Gross margin is 73.8%, with operating and profit margins of 0.48% and 0.35%.
| Gross Margin | 73.8% |
| Operating Margin | 0.48% |
| Pretax Margin | 0.63% |
| Profit Margin | 0.35% |
| EBITDA Margin | 0.48% |
| EBIT Margin | 0.48% |
| FCF Margin | 2.83% |
Dividends & Yields
MED pays an annual dividend of $8.23, which amounts to a dividend yield of 8.2%.
| Dividend Per Share | $8.23 |
| Dividend Yield | 8.2% |
| Dividend Growth (YoY) | 0.61% |
| Payout Ratio | 4331.58% |
| Earnings Yield | 1.09% |
| FCF Yield | 8.84% |
Analyst Forecast
The average price target for MED is $16.5, which is 37.3% higher than the current price. The consensus rating is "Hold".
| Price Target | $16.5 |
| Price Target Difference | 37.3% |
| Analyst Consensus | Hold |
| Analyst Count | 1 |
Scores
| Altman Z-Score | 4.66 |
| Piotroski F-Score | 6 |